Interview with Pfenex explores market access and pricing of biosimilars in North America
SMi Group has announced that Mr Patrick Lucy, CEO of Pfenex, has joined the speaker line-up for the 4th annual Biosimilars North America conference which takes place on November 15 & 16 in New Jersey.In the run-up to the conference, SMi Group had a quickfire interview with Patrick Lucy. Patrick will be presenting an exclusive session at the conference on where the market for biosimilars is heading, including key milestones and challenges overcome.
Asked about the level of biosimilar discounting is optimal and will we ever see price matching between branded and biosimilar products, Patrick said "Biosimilars are much more complex, requiring more resources and time to develop than small molecule drugs. In addition, there are far fewer players in the market. As such, discounts for biosimilar products have not been as steep as traditional generics. As a greater number of players enter the market and additional products are approved we will see greater competition, which will lead to greater access to needed treatments, positively impacting the lives patients – the ultimate goal.”
The full interview can be found on www.biosimilars-northamerica.com/openPR.
Patrick will present a special keynote address giving an overview of the biosimilars market, including the key milestones and hurdles the industry has overcome. He will also share some top tips on what to keep in mind moving forward.
He joins a speaker line-up comprised of experts shaping up the biosimilars landscape in North America including representatives from Sandoz, Harvest Moon Pharmaceuticals, Momenta, FUJIFILM Diosynth, Oncobiologics, Adelio, Covance, Zuckerman & Spaeder and more.
The full roster of speakers and their topics can be found on www.biosimilars-northamerica.com/openPR.
SMi’s Biosimilars North America conference will explore significant developmental topics within the sector including the impact of FDA’s newly implemented biosimilar interchangeability guidelines, the US market access landscape, and biosimilars of orphan drugs.
Registration is now live on the event website and there For more information visit: www.biosimilars-northamerica.com/openPR.
4th Biosimilars North America
November 15 & 16, 2017
Renaissance Woodbridge Hotel, Iselin, NJ, USA
www.biosimilars-northamerica.com/openPR
--- END ---
For delegate registration enquiries, contact Fateja Begum on fbegum@smi-online.co.uk. For media enquiries, contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
1
Westminster Bridge Road, SE1 7XW
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Interview with Pfenex explores market access and pricing of biosimilars in North America here
News-ID: 777391 • Views: …
More Releases from SMi Group
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK.
The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines.
Darren Green, Director of Computational Chemistry at GSK will be chairing at…
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety.
SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA.
The 2022 Conference theme is…
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022.
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering…
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.
Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022.
This event will convene on February 9th – 10th 2022,…
More Releases for Patrick
Author Patrick King Releases New Suspenseful Thriller – Boy Interrupted
Author Patrick King Releases New Suspenseful Thriller – Boy Interrupted
Author Patrick King is pleased to announce the release of his new suspenseful thriller, Boy Interrupted.
Boy Interrupted is a gripping and potent detective novel depicting the tortured early childhood and psychotic break of Kenny Hanson, a motherless boy raised by a pedophiliac father. Later, a dedicated team of investigators races to find the perpetrator and the motive behind a shocking…
Patrick Parsons appoints new Director to drive forward rail offering
Engineering consultancy Patrick Parsons has strengthened its management team with the appointment of a new Rail Director.
Sen Jay Dookayka has joined the firm’s Twickenham office to bolster its expertise within the rail sector.
In his new role, Sen Jay will lead the southern region and help grow the rail sector within Patrick Parsons by providing solutions aimed at improving the dependability of the railways.
With over 15 years’ experience, Sen Jay has…
Patrick Doczi Now Oversees North American Operations for NGC
Patrick Doczi, a four-year veteran of National Gift Card (NGC), has been named the company’s new Director of North American Operations, a role he sees as being essential to the ongoing development of a highly-focused customer service team.
Doczi, who most recently served as the Supervisor of the Activations Department at NGC, says helping all employees embrace a "can do" attitude is what continues to excite him.
"It’s fun to see everyone,…
Patrick Dunlap is leading tts North America
tts, market and innovation leader for digital learning and performance support technology has appointed Patrick Dunlap as SVP, Business Development - North America. Dunlap brings over 25 years of experience with Learning Tools, Electronic Performance Support Systems (EPSS) as well as Enterprise Software sales and global alliances. In his last appointment, Dunlap was responsible for Global Sales and Alliances at ANCILE Solutions, Inc.
Hermann Ude, Managing Partner of tts welcomed Patrick…
Capriotti’s Names Patrick Walls President
LAS VEGAS (January 10, 2011) – The leader in fresh and innovative sandwiches, Capriotti’s, announced the appointment of Patrick Walls to President of the company. Walls previously served as Chief Operating Officer for over two years with the company. Walls will be responsible for implementing and executing the strategy developed by the CEO and the Board of Directors as well as ensuring the company and each of its departments achieve…
View the Neuronal Impressionism of Patrick Girod at Agora Gallery
Chelsea’s Agora Gallery will feature French artist, Patrick Girod, in Enigmatic Realms. The exhibition is scheduled to run from January 11, 2011 through February 1, 2011 (opening reception: Thursday, January 13, 2011).
Patrick Girod’s work combines the ecstatic effulgence considered endemic to his native France with the strictness and humility associated with Switzerland. Working with oil on canvas in a traditional drip technique, Girod’s meandering compositions match the fanaticism of…